CELL MOL LIFE SCI 润色咨询

CELLULAR AND MOLECULAR LIFE SCIENCES

出版年份：1997 年文章数：4705 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：1.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-12-11 _mm 来自重庆

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）
    2022-7-6 under review
    2022-8-2 major revise
    2022-11-13 修回
    2022-11-30 小修
    2022-12-9 修回
    2022-12-10接收
    总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-01-30 Michael scofield123

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：细胞生物学
    经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept

    15

    展开15条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-12-27 ms3000001732307962 来自湖北省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：细胞;分子生物;肌肉
    经验分享：2022-10-30 submission
    2022-10-31 with editor
    2022-11-9 under review
    2022-12-6 Minor revision,
    2022-12-16 revised
    2022-12-19 accept
    审稿人意见很精辟，对内容把控的也很细致

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-19 ms4000000497560910

    请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2019-08-24 animal genetics

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：1，主要文章类型为review，只有少量article。
    2，对国人不是很友好。
    3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。
    4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。
    5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。
    6，不说了，换下一家期刊。。。。。。

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2020-07-10 ms9000001460504456

    请问这个杂志一般多久with editor？有这个状态没？ 着急

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-09-14 ms3000000389846462

    9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-03-17 NJMU-CNS

    谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-27 124d2c45m98暂无昵称

    请问，submitted to the journal 需要几天才能改变状态？

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2105364, encodeId=d024210536461, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：2022-7-1投稿（格式有问题，返回后7-2重新提交）<br>2022-7-6 under review<br>2022-8-2 major revise<br>2022-11-13 修回<br>2022-11-30 小修<br>2022-12-9 修回<br>2022-12-10接收<br>总得来说，效率很高。一、二、三审的时间，只有26天、17天、1天。ps：editor周末还工作，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5f1973612, createdName=_mm, createdTime=Sun Dec 11 13:18:33 CST 2022, time=2022-12-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学<br>经验分享：免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107698, encodeId=9864210e698c3, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：细胞;分子生物;肌肉<br>经验分享：2022-10-30 submission<br>2022-10-31 with editor<br>2022-11-9 under review<br>2022-12-6 Minor revision,<br>2022-12-16 revised<br>2022-12-19 accept<br>审稿人意见很精辟，对内容把控的也很细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Tue Dec 27 17:28:23 CST 2022, time=2022-12-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1233342, encodeId=e31c1233342f7, content=请问经历了两个under review ,每个都是10天，现在又进入下一个under review了，还有修的希望吗？一般是2个还是3个审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94988209714, createdName=ms4000000497560910, createdTime=Tue Jul 19 08:21:47 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575271, encodeId=50795e527107, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：1，主要文章类型为review，只有少量article。 <br> 2，对国人不是很友好。 <br> 3，审稿人很少或者也有可能是是期刊对审稿人要求高，所以少。 <br> 4，三次投稿经验综合来看，投稿到外审用时1-4周，一审时间2-3月。接收总体用时6月左右。 <br> 5，多数5分以上期刊是比较利落的，行就外审，不行就秒拒，不耽误作者投其他。但是这个期刊巨坑。有人从投稿到拿到一审用时4月，结果只有一个审稿人，结论还是拒稿。 <br> 6，不说了，换下一家期刊。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0171726353, createdName= animal genetics , createdTime=Sat Aug 24 13:32:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor？有这个状态没？ 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248958, encodeId=1da1124895855, content=9.9 submission，9.12 with editor，目前还没有变化，希望在编辑手里一周能出结果，要么under review，要么reject/transfer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da445615235, createdName=ms3000000389846462, createdTime=Wed Sep 14 21:54:55 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203486, encodeId=35d412034866f, content=谁能解释下CMLS三年平均IF 7.59，比好多生物学一区的都高，为什么不是一区杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Thu Mar 17 16:13:39 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234996, encodeId=ff93123499659, content=请问，submitted to the journal 需要几天才能改变状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Wed Jul 27 08:44:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234567, encodeId=a0fb123456e1b, content=请问，submitted to the journal 需要几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Mon Jul 25 11:30:44 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-25 124d2c45m98暂无昵称

    请问，submitted to the journal 需要几天呀

    0

共240条页码: 3/24页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分